Digital Transformation

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

Loyola Marymount University is expanding its EV charging with ChargePoint's AI platform and maintenance service, creating a reliable network for its community.

The latest VyOS release adds TLS for syslog, AWS GWLB support, and RPKI controls, boosting security and flexibility for modern network infrastructures.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

Danish water tech firm Aquaporin seeks urgent funding, warning of 77% dilution for shareholders as it races to secure its future and new technology.

A new joint venture aims to redefine Tallinn's skyline with a potential 60-storey high-rise, part of a major expansion in the Manufaktuuri quarter.

Danish Aerospace Company appoints HC Andersen Capital as its new Certified Advisor, a proactive move prompted by Baker Tilly's exit from the CA market.

T'way Air launches aggressive year-end deals for Seoul and Jeju, sparking a price war among low-cost carriers on the popular Singapore-Korea travel route.

With backing from AstraZeneca and Pfizer, Beijing’s Syneron Bio is using its AI-driven platform to develop novel drugs for cancer and chronic illness.

One Times Square now offers limited-time tickets for an up-close look at the famous New Year's Eve Ball before the building's grand 2026 reopening.

Following PwC's resignation, the private credit firm's move to MNP signals a new chapter in its financial governance as it streamlines operations.

The Canadian retailer's Q3 results show strong sales growth, but a sharp drop in net earnings reveals the high price of its ambitious turnaround plan.

Shaklee's Pomifera brand hires Christina Maniscalco, an expert from Beautycounter and Crunchi, to redefine its direct sales strategy and partner support.

Nuveen is combining three tax-free income funds. For investors, this means lower fees and stable payouts, but also new state tax implications.

Titan Mining's new funding aims to end a 70-year U.S. graphite production gap, a critical move for the nation's EV and energy independence goals.

A new oral drug, cadisegliatin, enters a major clinical trial in the UAE, aiming to help Type 2 diabetes patients struggling with insulin therapy.

Ottawa's National Gallery unveils new exhibits and family fun with free admission for youth, blending high art with interactive holiday experiences.

Avocado giant Mission Produce sets a new course, naming a successor to its founder CEO and refreshing its board to navigate future global market demands.

Altus Power acquires over 100 solar and storage sites from Greenbacker, boosting its capacity to 1.3 GW and signaling a new phase of consolidation.

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.